Cargando…
2380. Fecal Collinsella Abundance is Negatively Associated with Toxin A/B Production in Cancer Patients with Clostridioides difficile
BACKGROUND: The detection of C. difficile (CDI) by nucleic acid amplification test (NAAT) with negative toxin enzyme immunoassay (EIA-) is difficult to interpret in cancer patients. Markers that differentiate true infection from colonization, and are associated with clinical outcomes are needed. We...
Autores principales: | A. Francisco, Denise Marie, Olvera, Adilene, Zhang, Liangliang, Yepez Guevara, Eduardo, Garey, Kevin W, Peterson, Christine, Do, Kim-Anh, Dillon, Ryan J, Jenq, Robert, Okhuysen, Pablo C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810109/ http://dx.doi.org/10.1093/ofid/ofz360.2058 |
Ejemplares similares
-
2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019) -
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer
por: Francisco, Denise Marie A., et al.
Publicado: (2022) -
798. Metronidazole Exposure Prior to Clostridiodes difficile Infection (CDI) is a Risk Factor for Severe C. difficile Disease in Cancer Patients
por: Francisco, Denise Marie A, et al.
Publicado: (2020) -
Ribotypes Matter, Significance of Clostridium difficile Ribotypes in Cancer Patients with Diarrhea
por: Guevara, Eduardo Yepez, et al.
Publicado: (2017) -
Simultaneous detection and ribotyping of Clostridioides difficile, and toxin gene detection directly on fecal samples
por: van Rossen, Tessel M., et al.
Publicado: (2021)